Enable JavaScript to ensure website accessibility
Precipio Announces Preliminary Q1 2018 Year-Over-Year Revenue Increase Of 286%

Growth resulting from commercial team reorganization, product and service cross-selling, and increased business stabilization NEW [...]

Precipio Announces Participation Details For Upcoming Shareholder Conference Call

NEW HAVEN, CT, (April 26th, 2018) – Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), provides details of [...]

Precipio Completes A $3M Convertible Debt Facility

Management focuses on growth opportunities NEW HAVEN, CT, (April 23rd, 2018) – Specialty cancer diagnostics company Precipio, [...]

Precipio In Strategic Partnership Discussions For Proprietary Cytogenetics Media IV-Cell

NEW HAVEN, CT, (April 18th, 2018) – Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced today it [...]

Precipio Releases Its 2017 10-K, Files A Form S-1, And Hosts Fourth Quarter And Full Year Update Call

Management to provide strategic business update to shareholders NEW HAVEN, CT, (April 17th, 2018) – Specialty [...]

Precipio Launches ICE COLD-PCR™ Research Access Program For Cancer Centers

Complimentary Precipio ICE COLD PCR™ reagents now available to advance body of research and accelerate [...]

Important JAMA Article Underscores Superiority Of Precipio’s Liquid Biopsy Core Technology

Study cites major accuracy flaws in predominant liquid biopsy platforms offered by competitors NEW HAVEN, [...]

Precipio Files Patent For Non-Invasive Cell Capture Device For Gynecological Cancer Detection

In collaboration with Yale, feminine panty liner designed to remove obstacles to early detection NEW [...]

Precipio Enters India Liquid Biopsy Market With Adoption By Leading Laboratory

CORE Diagnostics to transition to Precipio’s price competitive ICE COLD-PCR™ platform NEW HAVEN, CT, (March [...]

Precipio Restructures Capitalization Table

Investors to convert preferred shares and exercise warrants NEW HAVEN, CT, (March 22nd, 2018) – Specialty [...]